Blood advances
UBE2O AS A KEY REGULATOR OF DRUG-INDUCED ERYTHROPOIESIS IN THE CONTEXT OF MYELODYSPLASTIC SYNDROMES.
Beatrice Maffeo, Cristina Panuzzo, Arianna Savi, Federico Itri, Simone Piccioli, Alice Costanza Danzero, Alessandro Maglione, Silvia Marini, Maria Teresa Voso, Carmen Fava, Enrico Bracco, Barbara Pergolizzi, Daniela Cilloni
Published: 202510.1182/bloodadvances.2025017340
Abstract
Ineffective erythropoiesis and the resulting anemia are the main characteristics of myelodysplastic syndromes (MDS). Drugs designed to promote erythropoiesis in MDS patients include erythropoiesis-stimulating agents such as recombinant human erythrop…
Preview only. Read the full abstract at the source